Deleted Tweets From Scott Gottlieb, R-D.C.

#Flu activity continues to increase across the U.S. Remember 3 steps to #fightflu: 1⃣ Get yourself & your family a flu shot 2⃣ Take everyday preventive actions 3⃣ Take antiviral drugs, if your doctor prescribes them https://t.co/6UrDYZ3wrd

RT @califf001: Amazing how good science and epidemiology can get to the key components of an issue. https://t.co/idJyaWbVWm QT @SGottliebFDA: My statement on #FDA’s new information related to safety concerns and adverse events associated with kratom:… https://t.co/1HLRRGuYd9)

We’re proud of FDA’s efforts to spark drug competition: 1,000+ generic drugs were approved in 2017 and we’re working to make our drug reviews more efficient to continue the trend https://t.co/cof9up6ktN https://t.co/WG0Mmt1XRb

RT @StephCaccomo: FDA's #digitalhealth team is looking for an engineer to join the team! Play a key role in developing the next gener… https://t.co/45YSL8O1ra

Helpful tips from @CDCgov - Most people with #flu have mild illness and don’t need medical care. However, stay alert for emergency warning signs of flu sickness, which include: - Difficulty breathing - Symptoms improve but return with a fever and worse co

RT @FDAMedia: FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging: https://t.co/buHs15DC29

New policy documents from #FDA are aimed at fostering generic drug development for some hard to cope medicines https://t.co/j85vjePDKb

RT @US_FDA: The 2017 Office of Generic Drugs Annual Report provides more details on how FDA’s generic drug program benefits pub… https://t.co/UZBshTntCz

.@US_FDA Adds 35 New, 22 Revised Product-Specific Guidances for Generic Drugmakers | #Regulatory Focus https://t.co/SiniBWHMfF #FDA #pharma #genericdrugs via @RAPSorg https://t.co/djK8Dhr9Ma

My statement on a groundbreaking new #FDA approval and interagency collaboration to bring stable supply of critical medical imaging isotope to the U.S. https://t.co/PXSDJuHjZO

RT @NNSANews: Just announced: #NNSA partnership with #healthcare industry results in @US_FDA approval of domestic production of… https://t.co/3SB4RTTHoA

No Nationwide Shortage: 13 rapid #flu tests available showing acceptable clinical performance https://t.co/mBX1Gkgc6e https://t.co/RCq4PaLJtn

RT @TomBossert45: Great work! FDA approves new process to conduct life saving medical screenings, bring jobs home, and keep dangerous nucle… QT @NNSANews: Just announced: #NNSA partnership with #healthcare industry results in @US_FDA approval of domestic production of… https://t.co/3SB4RTTHoA)

HR1892 passes; the brief shutdown will end when POTUS signs this AM; and the professional staff of @US_FDA will be back at their posts today tackling flu, promoting innovation, protecting consumers, and advancing America’s public health https://t.co/91Vhq

#FDA will be updating our website in the morning; and I’ll communicating directly with our staff in early hours of tomorrow; pending outcome of budget negotiations tonight. We hope for a swift resolution that keeps all our professional staff on the job, p

This year’s vaccine is effective against the circulating H1N1 and B strains of the #flu; and the spread of H1N1 tends to peak later in the flu season. It’s not too late to get vaccinated https://t.co/SsRJ8cKtWZ QT @CDCDirector: We continue to recommend getting the #flu vaccine to prevent flu. It’s true that flu vaccines often have lower effe… https://t.co/Q5jRnZYLG1)

RT @NCIDirector: #Precisionmedicine holds incredible promise in improving outcomes for #cancerpatients. Livestream available at… https://t.co/r1tPsAZuPa

RT @BioCentury: FDA unveils system to facilitate patient meeting requests https://t.co/uLVLwryOOC

RT @mcipriano93: US FDA Releases Slew Of Guidances On A Fell Day For Complex Generics https://t.co/S2KwWXLMPs

Recommended 2018 immunization schedule for children and adolescents 18 or younger in the U.S. now available in @CDCMMWR #VaccinesWork https://t.co/e0Fp1eXkB2 https://t.co/oSyIPLQKYo

With science moving so fast, the pipeline offers many promising opportunities for terminal diseases. We remain committed to safely and effectively advancing these programs; and at the same time giving those facing a terminal illness today a chance to acce

#FDA committed to working closely w/Congress to advance #RightToTry legislation that gives terminal patients chance to access promising treatments as part of our commitment to promote public health options. We're working closely with legislators; providin

During my tenure as #FDA Commissioner, I’ve been working closely with stakeholders to advance opportunities to ensure options for those patients diagnosed with terminal illness; including steps to improve our own Expanded Access programs to facilitate acc

#RightToTry policies rooted in strong desire to help patients facing terminal illnesses access experimental therapies with hope these treatments will help. #FDA shares the administration’s goal to help patients facing terminal diagnosis access promising t

RT @LauraMclinn: @SGottliebFDA Dr. Gottlieb, Thank you for your shared passion to help terminally ill patients. Sending love from th… https://t.co/SDOvMS4VNF

At the same time, we're committed to making the development process for breakthrough treatments more efficient and modern, so promising drugs can prove safety and efficacy sooner; and preserving the integrity of policies that make #FDA approval the gold s

Read more about some of the steps we've taken to improve our Expanded Access programs here: https://t.co/pKtMy7rTYh … We'll be announcing some new steps in coming months as we make sure our programs work to help patients who face terminal disease get acce

You can read more about some of the steps we've taken to improve our Expanded Access programs: https://t.co/pKtMy7rTYh We'll be announcing some new steps in coming months as we make sure our programs work to help patients who face terminal disease get acc

RT @DonnaYoungDC: #RightToTry #compassionateuse #FDA #pharma #biotech https://t.co/ihO5IHaH3W QT @SGottliebFDA: Read more about some of the steps we've taken to improve our Expanded Access programs here: https://t.co/pKtMy7rTYh… https://t.co/UQdx5lRMZI)

RT @FDAcdrhIndustry: #DidYouKnow https://t.co/dM65sc44Em QT @SGottliebFDA: Helpful tips from @CDCgov - Most people with #flu have mild illness and don’t need medical care. However, stay aler… https://t.co/3ZG6nQ9RDm)

1/3 This year the #flu has been widespread, impacting millions of patients across the country, and leading to a new record number of flu-related hospitalizations, surpassing those in the 2014-2015 flu season

2/3 People want to know why the level of protection they expect from their annual flu vaccine is diminished. We share the concern and are working with our @CDCFlu colleagues to determine why this season’s vaccine is offering suboptimal protection for H3N2

3/3 #FDA is committed to collaborating with other health agencies to use the lessons that we are learn — and will continue to learn -- from this year’s #flu outbreak and our evaluation of the seasonal vaccine to prepare for next year

1/3 #FDA works with gov’t partners to select strains for the annual #flu vaccine. Flu vaccines are adapted yearly based on science-based predictions of strains most likely to hit U.S. next season. It’s based on imp data, research, expertise; but unfortuna

RT @FDAOncology: In 2017, @FDAOncology approved 17 new drug and biologic applications, 32 supplemental drug and biologic application… https://t.co/JCLpPEab2J

3/3 There are several potential reasons why we may be seeing less than optimal protection from this year's vaccine that are being investigated. We're actively working on elucidating the causes with colleagues at @CDCFlu and we'll communicate this week as

2/3 While yearly #flu vaccines will likely never provide 100% protection against the flu (we always see differences in strains from year to year) it appears this year’s vaccine is offering suboptimal protection for H3N2 - this most predominant strain the

RT @DepSecHargan: Great to be at the @AccessibleMeds annual conference talking about our work to lower #DrugPrices. https://t.co/8wd7HXArwc

1/2 #FDA plays an important role in protecting public health by working with partners to select strains for the annual #flu vaccine based on best scientific predictions of the strains most likely to hit next season.

2/2 The just announced March 1 meeting of the Vaccines & Related Biological Products Advisory Committee (VRBPAC) will use lessons learned this year to make recommendations on selection of strains to be included in flu vaccines for 2018-2019: https://t

RT @FDAOncology: March 15 #OCEListens18 Oncology Center of Excellence public listening session. Registration:… https://t.co/Hrb4lG5bUX

RT @NCIDirector: NEW online Cancer Trends Progress Report provides up-to-date measures of progress across the #cancer control contin… https://t.co/zne8I912qT

What is the difference between a biosimilar and an interchangeable product? Visit FDA’s website to find out. https://t.co/NpfezOhhS1 https://t.co/fCqba4wiN2

RT @FDA_Drug_Info: FDA requires that #generics meet the same high standards as brand-name drugs do. Get the facts this #HeartMonth.… https://t.co/T5CmmiJCjq

RT @FDA_ORA: FDA’s Special Agents/@TheJusticeDept: NY oncologist & spouse to pay $500K for submitting false Medicare claims for… https://t.co/n5yhAWtB56

FDA requires that #generics meet the same high standards as brand-name drugs do. Get the facts this #HeartMonth. https://t.co/YS5CBjK0DA https://t.co/8dAcfgOBPh

#FDA is grateful for the Administration’s continued support of its vital public health mission and the resources for initiatives that we believe will ultimately lead both to better health outcomes for American families and greater U.S. economic developmen

RT @FDAMedia: FDA request for funds to promote innovation, broaden patient access: https://t.co/R6wJwIWjQ8

My statement: FY19 budget req funds #FDA’s current programs at consistent levels/support core public health mission. It also includes addtl ~$400M to advance initiatives to further promote innovation/competition & advance health/safety of American fam

RT @FDA_Track: Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote in… https://t.co/CQOYzZp4ua

#Flu activity continues to increase across the U.S. Remember 3 steps to #fightflu: 1⃣ Get yourself & your family a flu shot 2⃣ Take everyday preventive actions 3⃣ Take antiviral drugs, if your doctor prescribes them https://t.co/6UrDYZ3wrd

RT @califf001: Amazing how good science and epidemiology can get to the key components of an issue. https://t.co/idJyaWbVWm QT @SGottliebFDA: My statement on #FDA’s new information related to safety concerns and adverse events associated with kratom:… https://t.co/1HLRRGuYd9)

We’re proud of FDA’s efforts to spark drug competition: 1,000+ generic drugs were approved in 2017 and we’re working to make our drug reviews more efficient to continue the trend https://t.co/cof9up6ktN https://t.co/WG0Mmt1XRb

RT @StephCaccomo: FDA's #digitalhealth team is looking for an engineer to join the team! Play a key role in developing the next gener… https://t.co/45YSL8O1ra

Helpful tips from @CDCgov - Most people with #flu have mild illness and don’t need medical care. However, stay alert for emergency warning signs of flu sickness, which include: - Difficulty breathing - Symptoms improve but return with a fever and worse co

RT @FDAMedia: FDA and NRC pave way for the first domestic supply of the most commonly used medical isotope in diagnostic imaging: https://t.co/buHs15DC29

New policy documents from #FDA are aimed at fostering generic drug development for some hard to cope medicines https://t.co/j85vjePDKb

RT @US_FDA: The 2017 Office of Generic Drugs Annual Report provides more details on how FDA’s generic drug program benefits pub… https://t.co/UZBshTntCz

.@US_FDA Adds 35 New, 22 Revised Product-Specific Guidances for Generic Drugmakers | #Regulatory Focus https://t.co/SiniBWHMfF #FDA #pharma #genericdrugs via @RAPSorg https://t.co/djK8Dhr9Ma

My statement on a groundbreaking new #FDA approval and interagency collaboration to bring stable supply of critical medical imaging isotope to the U.S. https://t.co/PXSDJuHjZO

RT @NNSANews: Just announced: #NNSA partnership with #healthcare industry results in @US_FDA approval of domestic production of… https://t.co/3SB4RTTHoA

No Nationwide Shortage: 13 rapid #flu tests available showing acceptable clinical performance https://t.co/mBX1Gkgc6e https://t.co/RCq4PaLJtn

RT @TomBossert45: Great work! FDA approves new process to conduct life saving medical screenings, bring jobs home, and keep dangerous nucle… QT @NNSANews: Just announced: #NNSA partnership with #healthcare industry results in @US_FDA approval of domestic production of… https://t.co/3SB4RTTHoA)

HR1892 passes; the brief shutdown will end when POTUS signs this AM; and the professional staff of @US_FDA will be back at their posts today tackling flu, promoting innovation, protecting consumers, and advancing America’s public health https://t.co/91Vhq

#FDA will be updating our website in the morning; and I’ll communicating directly with our staff in early hours of tomorrow; pending outcome of budget negotiations tonight. We hope for a swift resolution that keeps all our professional staff on the job, p

This year’s vaccine is effective against the circulating H1N1 and B strains of the #flu; and the spread of H1N1 tends to peak later in the flu season. It’s not too late to get vaccinated https://t.co/SsRJ8cKtWZ QT @CDCDirector: We continue to recommend getting the #flu vaccine to prevent flu. It’s true that flu vaccines often have lower effe… https://t.co/Q5jRnZYLG1)

RT @NCIDirector: #Precisionmedicine holds incredible promise in improving outcomes for #cancerpatients. Livestream available at… https://t.co/r1tPsAZuPa

RT @BioCentury: FDA unveils system to facilitate patient meeting requests https://t.co/uLVLwryOOC

RT @mcipriano93: US FDA Releases Slew Of Guidances On A Fell Day For Complex Generics https://t.co/S2KwWXLMPs

Recommended 2018 immunization schedule for children and adolescents 18 or younger in the U.S. now available in @CDCMMWR #VaccinesWork https://t.co/e0Fp1eXkB2 https://t.co/oSyIPLQKYo

With science moving so fast, the pipeline offers many promising opportunities for terminal diseases. We remain committed to safely and effectively advancing these programs; and at the same time giving those facing a terminal illness today a chance to acce

#FDA committed to working closely w/Congress to advance #RightToTry legislation that gives terminal patients chance to access promising treatments as part of our commitment to promote public health options. We're working closely with legislators; providin

During my tenure as #FDA Commissioner, I’ve been working closely with stakeholders to advance opportunities to ensure options for those patients diagnosed with terminal illness; including steps to improve our own Expanded Access programs to facilitate acc

#RightToTry policies rooted in strong desire to help patients facing terminal illnesses access experimental therapies with hope these treatments will help. #FDA shares the administration’s goal to help patients facing terminal diagnosis access promising t

RT @LauraMclinn: @SGottliebFDA Dr. Gottlieb, Thank you for your shared passion to help terminally ill patients. Sending love from th… https://t.co/SDOvMS4VNF

At the same time, we're committed to making the development process for breakthrough treatments more efficient and modern, so promising drugs can prove safety and efficacy sooner; and preserving the integrity of policies that make #FDA approval the gold s

Read more about some of the steps we've taken to improve our Expanded Access programs here: https://t.co/pKtMy7rTYh … We'll be announcing some new steps in coming months as we make sure our programs work to help patients who face terminal disease get acce

You can read more about some of the steps we've taken to improve our Expanded Access programs: https://t.co/pKtMy7rTYh We'll be announcing some new steps in coming months as we make sure our programs work to help patients who face terminal disease get acc

RT @DonnaYoungDC: #RightToTry #compassionateuse #FDA #pharma #biotech https://t.co/ihO5IHaH3W QT @SGottliebFDA: Read more about some of the steps we've taken to improve our Expanded Access programs here: https://t.co/pKtMy7rTYh… https://t.co/UQdx5lRMZI)

RT @FDAcdrhIndustry: #DidYouKnow https://t.co/dM65sc44Em QT @SGottliebFDA: Helpful tips from @CDCgov - Most people with #flu have mild illness and don’t need medical care. However, stay aler… https://t.co/3ZG6nQ9RDm)

1/3 This year the #flu has been widespread, impacting millions of patients across the country, and leading to a new record number of flu-related hospitalizations, surpassing those in the 2014-2015 flu season

2/3 People want to know why the level of protection they expect from their annual flu vaccine is diminished. We share the concern and are working with our @CDCFlu colleagues to determine why this season’s vaccine is offering suboptimal protection for H3N2

3/3 #FDA is committed to collaborating with other health agencies to use the lessons that we are learn — and will continue to learn -- from this year’s #flu outbreak and our evaluation of the seasonal vaccine to prepare for next year

1/3 #FDA works with gov’t partners to select strains for the annual #flu vaccine. Flu vaccines are adapted yearly based on science-based predictions of strains most likely to hit U.S. next season. It’s based on imp data, research, expertise; but unfortuna

RT @FDAOncology: In 2017, @FDAOncology approved 17 new drug and biologic applications, 32 supplemental drug and biologic application… https://t.co/JCLpPEab2J

3/3 There are several potential reasons why we may be seeing less than optimal protection from this year's vaccine that are being investigated. We're actively working on elucidating the causes with colleagues at @CDCFlu and we'll communicate this week as

2/3 While yearly #flu vaccines will likely never provide 100% protection against the flu (we always see differences in strains from year to year) it appears this year’s vaccine is offering suboptimal protection for H3N2 - this most predominant strain the

RT @DepSecHargan: Great to be at the @AccessibleMeds annual conference talking about our work to lower #DrugPrices. https://t.co/8wd7HXArwc

1/2 #FDA plays an important role in protecting public health by working with partners to select strains for the annual #flu vaccine based on best scientific predictions of the strains most likely to hit next season.

2/2 The just announced March 1 meeting of the Vaccines & Related Biological Products Advisory Committee (VRBPAC) will use lessons learned this year to make recommendations on selection of strains to be included in flu vaccines for 2018-2019: https://t

RT @FDAOncology: March 15 #OCEListens18 Oncology Center of Excellence public listening session. Registration:… https://t.co/Hrb4lG5bUX

RT @NCIDirector: NEW online Cancer Trends Progress Report provides up-to-date measures of progress across the #cancer control contin… https://t.co/zne8I912qT

What is the difference between a biosimilar and an interchangeable product? Visit FDA’s website to find out. https://t.co/NpfezOhhS1 https://t.co/fCqba4wiN2

RT @FDA_Drug_Info: FDA requires that #generics meet the same high standards as brand-name drugs do. Get the facts this #HeartMonth.… https://t.co/T5CmmiJCjq

RT @FDA_ORA: FDA’s Special Agents/@TheJusticeDept: NY oncologist & spouse to pay $500K for submitting false Medicare claims for… https://t.co/n5yhAWtB56

FDA requires that #generics meet the same high standards as brand-name drugs do. Get the facts this #HeartMonth. https://t.co/YS5CBjK0DA https://t.co/8dAcfgOBPh

#FDA is grateful for the Administration’s continued support of its vital public health mission and the resources for initiatives that we believe will ultimately lead both to better health outcomes for American families and greater U.S. economic developmen

RT @FDAMedia: FDA request for funds to promote innovation, broaden patient access: https://t.co/R6wJwIWjQ8

My statement: FY19 budget req funds #FDA’s current programs at consistent levels/support core public health mission. It also includes addtl ~$400M to advance initiatives to further promote innovation/competition & advance health/safety of American fam

RT @FDA_Track: Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote in… https://t.co/CQOYzZp4ua